Levels of Metals in the Blood and Specific Porphyrins in the Urine in Children with Autism Spectrum Disorders

Biological Trace Element Research

Volumn 163, Issue 1-2, 2015, Pages 2-10

  Macedoni Lukšič, Marta ^a,b   Gosar, David ^a   Bjørklund, Geir ^c   Oražem, Jasna ^a   Kodrič, Jana ^a   Lešnik Musek, Petra ^a   Zupančič, Mirjana ^a   France Štiglic, Alenka ^d   Sešek Briški, Alenka ^d   Neubauer, David ^a   Osredkar, Joško ^d  

^a Dept of Developmental Neurology   (Slovenia)

^b Institute of Autism Spectrum Disorders   (Slovenia)

^c Department of Research   (Norway)

^d UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Autism; Children; Copper; Metals; Neurodevelopmental; Zinc

Indexed keywords

ALUMINUM; COPPER; COPROPORPHYRIN; COPROPORPHYRIN I; COPROPORPHYRIN III; HEPTACARBOXYPORPHYRIN I; HEXACARBOXYPORPHYRIN; LEAD; MERCURY; PENTACARBOXYPORPHYRIN I; PORPHYRIN; UNCLASSIFIED DRUG; UROPORPHYRIN; ZINC;

ADOLESCENT; ALUMINUM BLOOD LEVEL; ANALYTICAL PARAMETERS; ARTICLE; ASSESSMENT OF HUMANS; ATOMIC ABSORPTION SPECTROMETRY; AUTISM; BAYLEY SCALES OF INFANT DEVELOPMENT; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER ZINC RATIO; FEMALE; FLUORESCENCE ANALYSIS; HEAVY METAL BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MERCURY BLOOD LEVEL; RAVEN COLOR PROGRESSIVE MATRICES; SLOVENIA; URINALYSIS; WECHSLER INTELLIGENCE SCALE; ZINC BLOOD LEVEL; BLOOD; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; URINE;

CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; COPPER; FEMALE; HUMANS; MALE; PORPHYRINS; ZINC;

EID: 84922004497     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-014-0121-6     Document Type: Article

References (93)

1. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Association, Washington
2. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Association, Washington
3. Autism and Developmental Disabilities Monitoring Network Surveillance Year (2008) Principal Investigators; Centers for Disease Control and Prevention (2012) Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 61(3):1–19
4. Fombonne E (2009) Commentary: on King and Bearman. Int J Epidemiol 38:1241–1242
5. King M, Bearman P (2009) Diagnostic change and the increased prevalence of autism. Int J Epidemiol 38:1224–1234
6. Sinzig J, Walter D, Doepfner M (2009) Attention deficit/hyperactivity disorder in children and adolescents with autism spectrum disorder: symptom or syndrome? J Atten Disord 13:117–126
7. Anholt GE, Cath DC, van Oppen P, Eikelenboom M, Smit JH, van Megen H, van Balkom AJ (2010) Autism and ADHD symptoms in patients with OCD: are they associated with specific OC symptom dimensions or OC symptom severity? J Autism Dev Disord 40:580–589
8. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T et al (2011) Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 68:1095–1102
9. Rutter M (2005) Aetiology of autism: findings and questions. J Intellect Disabil Res 49:231–238
10. Casey JP, Magalhaes T, Conroy JM, Regan R, Shah N, Anney R et al (2012) A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet 131:565–79
11. Devlin B, Scherer SW (2012) Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev 22:229–237
12. Hertz-Picciotto I, Croen LA, Hansen R, Jones CR, van de Water J, Pessah IN (2006) The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect 114:1119–1125
13. Stoltenberg C, Schjølberg S, Bresnahan M, Hornig M, Hirtz D, Dahl C et al (2010) The autism birth cohort (ABC): a paradigm for gene-environment-timin research. Mol Psychiatry 15:676–680
14. Schendel DE, Diguisseppi C, Croen LA, Fallin MD, Schieve LA, Wiggins LD (2012) The study to explore early development (SEED): a multisite epidemiologic study of autism by the centers for autism and developmental disabilities research and epidemiology (CADDRE) network. J Autism Dev Disord 42:2121–2140
15. King MD, Fountain C, Dakhlallah D, Bearman PS (2009) Estimated autism risk and older reproductive age. Am J Public Health 99:1673–1679
16. Shelton JF, Tancredi DJ, Hertz-Picciotto I (2010) Independent and dependent contributions of advanced maternal and paternal ages to autism risk. Autism Res 3:30–39
17. Krakowiak P, Walker CK, Bremer AA, Baker AS, Ozonoff S, Hansen RL et al (2012) Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics 129:1121–1128
18. 12- and folate-deficient patients misincorporate uracil into DNA. Blood 83:1656–1661
19. Duthie SJ, Hawdon A (1998) DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J 12:1491–1497
20. Duthie SJ (1999) Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 55:578–592
21. Kapiszewska M, Kalemba M, Wojciech U, Milewicz T (2005) Uracil misincorporation into DNA of leukocytes of young women with positive folate balance depends on plasma vitamin B12 concentrations and methylenetetrahydrofolate reductase polymorphisms. A pilot study. J Nutr Biochem 16:467–478
22. Fenech M (2010) Folate, DNA damage and the aging brain. Mech Ageing Dev 131:236–241
23. Nakao LS, Augusto O (1998) Nucleic acid alkylation by free radical metabolites of ethanol. Formation of 8 (1-hydroxyethyl) guanine and 8-(2-hydroxyethyl)guanine adducts. Chem Res Toxicol 11:888–894
24. Nakao LS, Fonseca E, Augusto O (2002) Detection of C8-(1-hydroxyethyl)guanine in liver RNA and DNA from control and ethanol-treated rats. Chem Res Toxicol 15:1248–1253
25. Hori K, Miyamoto S, Yukawa Y, Muto M, Chiba T, Matsuda T (2012) Stability of acetaldehyde-derived DNA adduct in vitro. Biochem Biophys Res Commun 423:642–646
26. Singh R, Gromadzinska J, Mistry Y, Cordell R, Juren T, Segerbäck D, Farmer PB (2012) Detection of acetaldehyde derived N(2)-ethyl-2’-deoxyguanosine in human leukocyte DNA following alcohol consumption. Mutat Res 737:8–11
27. Kopf PG, Walker MK (2010) 2,3,7,8-tetrachlorodibenzo-p-dioxin increases reactive oxygen species production in human endothelial cells via induction of cytochrome P4501A1. Toxicol Appl Pharmacol 245:91–99
28. Beedanagari SR, Taylor RT, Hankinson O (2010) Differential regulation of the dioxin-induced Cyp1A1 and Cyp1B1 genes in mouse hepatoma and fibroblast cell lines. Toxicol Lett 194:26–33
29. 450 1A1 enzyme (CYP1A1) and aryl hydrocarbonreceptor (AhR) in the placenta. Curr Pharm Biotechnol 12:715–730
30. 450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice. Carcinogenesis 23:1199–1207
31. 450 1B1 in MDA-MB-231 human breast cancer cells by non-ortho-substituted polychlorinated biphenyls. Toxicol in Vitro 16:695–704
32. Brown DJ, Van Overmeire I, Goeyens L, Denison MS, De Vito MJ, Clark GC (2004) Analysis of Ah receptor pathway activation by brominated flame retardants. Chemosphere 55:1509–1518
33. Volk HE, Hertz-Picciotto I, Delwiche L, Lurmann F, McConnell R (2011) Residential proximity to freeways and autism in the CHARGE study. Environ Health Perspect 119:873–877
34. Schmidt RJ, Tancredi DJ, Ozonoff S, Hansen RL, Hertiala J, Allayee H et al (2012) Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE case-control study. Am J Clin Nutr 96:80–89
35. Shelton JF, Hertz-Picciotto I, Pessah IN (2012) Tipping the balance of autism risk: potential mechanisms linking pesticides and autism. Environ Health Perspect 120:944–951
36. Volk HE, Lurmann F, Penfold B, Hertz-Picciotto I, McConnell R (2013) Traffic-related air pollution, particulare matter, and autism. JAMA Psychiatry 70:71–77
37. Zerbo O, Iosif AM, Walker C, Ozonoff S, Hansen RL, Hertz-Picciotto I (2013) Is maternal influenza or fever during pregnancy associated with autism or developmetal delay? Results from the CHARGE study. J Autism Dev Disord 43:25–33
38. Aschwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, van de Walter J (2011) Association of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol 232:196–199
39. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J (2011) Altered T cell responses in children with autism. Brain Behav Immun 25:840–849
40. Braunschweig D, Duncanson P, Boyce R, Hansen R, Ashwood P, Pessah IN, Hertz-Picciotto I, Van de Water J (2012) Behavioral correlates of maternal antibody status among children with autism. J Autism Dev Disord 42:1435–1445
41. Shaw CA, Tomljenovic L (2013) Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity. Immunol Res 56:304–316
42. Kern JK, Geier DA, Audhya T, King PG, Sykes LK, Geier MR (2012) Evidence of parallels between mercury intoxication and the brain pathology in autism. Acta Neurobiol Exp (Wars) 72:113–153
43. Landrigan PJ (2010) What causes autism? Exploring the environmental contribution. Curr Opin Pediatr 22:219–225
44. Bjørklund G (2013) The role of zinc and copper in autism spectrum disorders. Acta Neurobiol Exp 73:225–236
45. Faber S, Zinn GM, Kern JC II, Kingston HMS (2009) The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders. Biomarkers 14:171–180
46. Yasuda H, Yoshida K, Yasuda Y, Tsutsui T (2011) Infantile zinc deficiency: association with autism spectrum disorders. Sci Rep 1:129. doi:10.1038/srep00129
47. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80:1611–1617
48. Bjørklund G (1991) Mercury in the dental office. Risk evaluation of the occupational environment in dental care (in Norwegian). Tidsskr Nor Laegeforen 111:948–951
49. Stejskal V (2013) Mercury-induced inflammation: yet another example of ASIA syndrome. Isr Med Assoc J 15:714–715
50. Brester MA (1988) Biomarkers of xenobiotic exposures. Ann Clin Lab Sci 18:306–317
51. Geier DA, Geier MR (2006) A prospective assessement of porphyrins in autistic disorders: a potential marker for heavy metal exposure. Neurotox Res 10:57–64
52. Nataf R, Skorupka C, Amet L, Lam A, Springbett A, Lathe R (2006) Porphyrinuria in childhood autistic disorder: implications for enviromental toxicity. Toxicol Appl Pharmacol 214:99–108
53. Wang L, Angley MT, Gerber JP, Sorich MJ (2011) A review of candidate urinary biomarkers for autism spectrum disorder. Biomarkers 16:537–552
54. Kimbrough RD (1987) Porphyrins and hepatotoxicity. Ann N Y Acad Sci 514:289–296
55. Van Meter JR, Tierney KR, Pittelkow MR (2011) Iron, genes, and viruses: the porphyria cutanea tarda triple threat. Cutis 88:73–76
56. Bonkovsky HL, Guo JT, Hou W, Li T, Narang T, Thapar M (2013) Porphyrin and heme metabolism and the porphyrias. Compr Physiol 3:365–401
57. Chauhan A, Chauhan V, Brown T (2010) Autism: oxidative stress, inflammation, and immune abnormalities. CRC Press, Boca Raton
58. Sarkany RP (1999) Porphyria. From Sir Walter Raleigh to molecular biology. Adv Exp Med Biol 455:235–241
59. Gross U, Hoffmann GF, Doss MO (2000) Erythropoietic and hepatic porphyrias. J Inherit Metab Dis 23:641–661
60. Woods JS (2005) The association between genetic polymorphisms of coproporphyrinogen oxidase and an atypical porphyrinogenic response to mercury exposure in humans. Toxicol Appl Pharmacol 206:113–120
61. Cohen DJ, Johnson WT, Caparulo BK (1976) Pica and elevated blood lead level in autistic and atypical children. Am J Dis Child 130:47–48
62. Prasad AS (2012) Discovery of human zinc deficiency: 50 years later. J Trace Elem Med Biol 26:66–69
63. Johnson F, Giulivi C (2005) Superoxide dismutases and their impact upon human health. Mol Aspects Med 26:340–352
64. Nozik-Grayck E, Suliman HB, Piantadosi CA (2005) Extracellular superoxide dismutase. Int J Biochem Cell Biol 37:2466–2471
65. Zimnicka AM, Maryon EB, Kaplan JH (2007) Human copper transporter hCTR1 mediates basolateral uptake of copper into enterocytes: implications for copper homeostasis. J Biol Chem 282:26471–26480
66. DiGirolamo AM, Ramirez-Zea M (2009) Role of zinc in maternal and child mental health. Am J Clin Nutr 89:940S–945S
67. Plum LM, Rink L, Haase H (2010) The essential toxin: impact of zinc on human health. Int J Environ Res Public Health 7:1342–1365
68. Suhy DA, Simon KD, Linzer DI, O’Halloran TV (1999) Metallothionein is part of a zinc-scavenging mechanism for cell survival under conditions of extreme zinc deprivation. J Biol Chem 274:9183–9192
69. Banci L, Bertini I, Ciofi-Baffoni S, Kozyreva T, Zovo K, Palumaa P (2010) Affinity gradients drive copper to cellular destinations. Nature 465:645–648
70. Kang YJ (2006) Metallothionein redox cycle and function. Exp Biol Med (Maywood) 231:1459–1467
71. Underwood EA (1977) Trace elements in human and animal nutrition, 4th edn. Academic, New York
72. Davis GK, Mertz W (1987) Copper. In: Mertz W (ed) Trace elements in human and animal nutrition, vol 1, 4th edn. Academic, San Diego, pp 301–364
73. 2-macroglobulin in human plasma. Cell Stress Chaperones 18:161–170
74. Russo AJ, deVito R (2011) Analysis of copper and zinc plasma concentration the efficacy of zinc therapy in individuals with Asperger’s syndrome, pervasive developmental disorder not otherwise specified (PDD-NOS) and autism. Biomark Insights 6:127–133
75. Carver PL (2013) Metal ions and infectious diseases. An overview from the clinic. Met Ions Life Sci 13:1–28
76. Rainsford KD (1998) Copper and zinc in inflammatory and degenerative diseases. Kluwer Academic Publishers, Dordrecht
77. Goggs R, Vaughan-Thomas A, Clegg PD, Carter SD, Innes JF, Mobasheri A, Shakibaei M, Schwab W, Bondy CA (2005) Nutraceutical therapies for degenerative joint diseases: a critical review. Crit Rev Food Sci Nutr 45:145–164
78. Strauss E, Shernan EM, Spreen O (2006) A compendium of neuropsychological tests, 3rd edn. Oxford University Press, New York
79. Parker SK, Schwartz B, Todd J, Pickering LK (2004) Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 114:793–803
80. Boben D (2003) Slovenska standardizacija Ravenovih progresivnih matric: norme za CPM. SPM in APM. Center za psihodiagnostična sredstva, Ljubljana
81. Kiddie JY, Weiss MD, Kitts DD, Levy-Milne R, Wasdell MB (2010) Nutritional status of children with attention deficit hyperactivity disorder: a pilot study. Int J Pediatr 2010:767318. doi:10.1155/2010/767318
82. Dufault R, Schnoll R, Lukiw WJ, Leblanc B, Cornett C, Patrick L, Wallinga D, Gilbert SG, Crider R (2009) Mercury exposure, nutritional deficiencies and metabolic disruptions may affect learning in children. Behav Brain Funct 5:44. doi:10.1186/1744-9081-5-44
83. Hertz-Picciotto I, Green PG, Delwiche L, Hansen R, Walker C, Pessah IN (2009) Blood mercury concentrations in CHARGE Study children with and without autism. Environ Health Perspect 118:161–166
84. Clarkson TW, Friberg L, Nordberg GF, Sager P (1988) Biological monitoring of metals. Plenum Press, New York
85. IPCS—International Programme on Chemical Safety (1991) Environmental Health Criteria 118: inorganic mercury. WHO, Geneva
86. Vieira FM, Nakhle MC, Abrantes-Lemos CP, Cançado EL, dos Reis VM (2013) Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients. An Bras Dermatol 88:530–540
87. Liu SW, Lien MH, Fenske NA (2010) The effects of alcohol and drug abuse on the skin. Clin Dermatol 28:391–399
88. Peters HA, Gocmen A, Cripps DJ, Bryan GT, Dogramaci I (1982) Epidemiology of hexachlorobenzene-induced porphyria in Turkey: clinical and laboratory follow-up after 25 years. Arch Neurol 39:744–749
89. Hornig M, Chian D, Lipkin WI (2004) Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol Psychiatry 9:833–845
90. Gerecht M, Austin DW (2011) The plausibility of a role for mercury in the etiology of autism: a cellular perspective. Toxicol Environ Chem 93:1251–1273
91. Stamova B, Green PG, Tian Y, Hertz-Picciotto I, Pessah IN, Hansen R et al (2011) Correlations between gene expression and mercury levels in blood of boys with and without autism. Neurotox Res 19:31–48
92. Thompson MR, Boekelheide K (2013) Multiple environmental chemical exposures to lead, mercury and polychlorinated biphenyls among childbearing-aged women (NHANES 1999-2004): body burden and risk factors. Environ Res 121:23–30
93. Sarigiannis DA, Hansen U (2012) Considering the cumulative risk of mixtures of chemicals – a challenge for policy makers. Environ Health 11 Suppl 1:S18. doi:10.1186/1476-069X-11-S1-S18